LUXA
Income statement / Annual
Last year (2021), Lux Health Tech Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2021, Lux Health Tech Acquisition Corp.'s net income was $55.38 M.
See Lux Health Tech Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2021
|
FY-2020
|
Period Ended |
12/31/2021 |
12/31/2020 |
Operating Revenue |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
Research and Development Expenses |
$0.00
|
$0.00
|
General & Administrative Expenses |
$978,762.00
|
$183,040.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$978,762.00
|
$183,040.00
|
Other Expenses |
$0.00
|
$0.00
|
Operating Expenses |
$978,762.00
|
$183,040.00
|
Cost And Expenses |
$978,762.00
|
$183,040.00
|
Interest Income |
$0.00
|
$0.00
|
Interest Expense |
-$28.28 M
|
$0.00
|
Depreciation & Amortization |
$28.28 M
|
$3,572.00
|
EBITDA |
$27.10 M |
-$244,723.00 |
EBITDA Ratio |
0
|
0
|
Operating Income Ratio |
0
|
0
|
Total Other Income/Expenses Net |
$28.28 M
|
$3,572.00
|
Income Before Tax |
$27.10 M
|
-$244,723.00
|
Income Before Tax Ratio |
0
|
0
|
Income Tax Expense |
-$28.28 M
|
$0.00
|
Net Income |
$55.38 M
|
-$244,723.00
|
Net Income Ratio |
0
|
0
|
EPS |
1.28 |
-0.0057 |
EPS Diluted |
1.28 |
-0.0057 |
Weighted Average Shares Out |
$43.12 M
|
$43.12 M
|
Weighted Average Shares Out Diluted |
$43.12 M
|
$43.12 M
|
Link |
|
|